Lamotrigine Ratiopharm® (Lamotrigine)

Lamotrigine works by inhibiting voltage‑gated sodium channels on neurons, which dampens rapid depolarisation and limits the release of excitatory neurotransmitters such as glutamate. This stabilises neuronal membranes and reduces the hyper‑excitability that contributes to seizures and mood fluctuations.

The dosage of lamotrigine is individualised and set by the prescribing clinician. Initial therapy typically starts with a low dose that is gradually increased (titrated) over weeks to achieve therapeutic levels while minimising the risk of skin reactions. Exact amounts depend on the indication, patient age, and co‑medications.

Safety data for lamotrigine during pregnancy and lactation are limited, and the drug is classified as having an unknown pregnancy category. Healthcare providers should weigh potential benefits against possible risks, discuss alternatives, and monitor both mother and infant closely if treatment is continued.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Compared with older sodium‑channel blockers such as carbamazepine, lamotrigine has a broader spectrum covering both focal and generalized seizures and offers mood‑stabilising benefits for bipolar disorder. It generally has a lower risk of enzyme‑inducing drug interactions but requires careful titration to avoid skin‑related adverse events.

Store the tablets at ambient temperature, preferably below 25 °C, in the original blister pack or container. Protect them from excess moisture and direct sunlight. Do not refrigerate or freeze the product, and keep it out of reach of children.

Lamotrigine Ratiopharm® is supplied as oral tablets that should be swallowed whole with water. It can be taken with or without food, but consistency with meals may help reduce gastrointestinal upset. Dosing schedules are determined by the prescriber and may involve gradual titration.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood disorders like agranulocytosis, significant hepatic injury, and the emergence of suicidal thoughts or behaviours. Patients should seek immediate medical attention if they notice rash, fever, jaundice, or mood changes.

Lamotrigine is contraindicated in individuals with a known hypersensitivity to the drug or any of its excipients. Patients with severe hepatic impairment should avoid use, and those taking interacting medications that drastically alter lamotrigine levels should be evaluated carefully by a healthcare professional.